Valuation: AroCell AB

Market Cap 96.98M 9.98M 8.75M 8.07M 7.55M 14.17M 942M 14.46M 37.53M 465M 37.49M 36.67M 1.61B P/E 2024
-2.12x
P/E 2025 -6.69x
Enterprise Value 73.64M 7.58M 6.65M 6.13M 5.74M 10.76M 715M 10.98M 28.5M 353M 28.47M 27.85M 1.23B EV / Sales 2024
0.73x
EV / Sales 2025 1.09x
Free-Float
58.63%
Yield 2024 *
-
Yield 2025 -
1 day+5.23%
1 week+5.98%
Current month-7.71%
1 month-7.71%
3 months+59.35%
6 months+36.73%
Current year+25.50%
1 week 0.38
Extreme 0.38
0.45
1 month 0.38
Extreme 0.38
0.51
Current year 0.25
Extreme 0.25
0.53
1 year 0.25
Extreme 0.25
0.58
3 years 0.25
Extreme 0.25
0.66
5 years 0.25
Extreme 0.25
6.7
10 years 0.25
Extreme 0.25
8.45
Manager TitleAgeSince
Chief Executive Officer - 2026-05-27
Director of Finance/CFO - 2022-08-17
Chief Tech/Sci/R&D Officer - 2024-12-31
Director TitleAgeSince
Director/Board Member 56 2019-12-31
Chairman 39 2024-05-21
Director/Board Member 74 2022-12-31
Date Insider Type Main position Quantity % Market Cap.
21-09-01Buy

Executive/Senior Manager

25,000 0.0220%
21-09-01Buy 20,000 0.0176%
21-08-31Buy

Director

5,353 0.0047%
Change 5-day change 1-year change 3-year change Capi.($)
+5.23%+5.98%-15.78%-14.15% 9.98M
+0.32%+7.27%-4.99%+2.64% 46.2B
+2.19%+11.71%+393.31%+580.42% 38.71B
+2.53%+13.93%+21.38%-12.81% 31.9B
+1.65%+3.61%+16.04%+55.62% 31.12B
-4.16%-2.58%+8.94%+25.31% 23.77B
-0.32%+12.96% - - 16.2B
+1.37%+14.53%+69.64%+130.07% 15.05B
-1.39%+7.12%+12.51%+20.35% 13.74B
+3.63%+9.53%+103.97%+98.73% 13.42B
Average +1.25%+7.58%+67.22%+98.46% 23.01B
Weighted average by Cap. +0.96%+8.71%+88.83%+131.24%

Financials

2024 2025
Net sales 57.44M 5.91M 5.18M 4.78M 4.47M 8.39M 558M 8.56M 22.22M 276M 22.2M 21.72M 956M 53.11M 5.47M 4.79M 4.42M 4.14M 7.76M 516M 7.92M 20.55M 255M 20.53M 20.08M 884M
Net income -42.45M -4.37M -3.83M -3.53M -3.31M -6.2M -412M -6.33M -16.43M -204M -16.41M -16.05M -706M -12.15M -1.25M -1.1M -1.01M -946K -1.77M -118M -1.81M -4.7M -58.32M -4.7M -4.59M -202M
Net Debt -47.78M -4.92M -4.31M -3.98M -3.72M -6.98M -464M -7.12M -18.49M -229M -18.47M -18.07M -795M -23.34M -2.4M -2.11M -1.94M -1.82M -3.41M -227M -3.48M -9.03M -112M -9.02M -8.82M -388M
Logo AroCell AB
IDL Diagnostics AB (publ), formerly AroCell AB (publ), is a Sweden-based diagnostic Company engaged in the biotechnology and medical diagnostics industry. The Company focuses on research, development, manufacturing, and commercialization of diagnostic and medical technology products. The Company has a broad product portfolio of In Vitro Diagnostics (IVD) tests that deliver clinical information for the detection of disease with indications spanning everything from urological cancers to typhoid fever. IDL Diagnostics AB (publ) develops tests that are clinically useful and economically viable. The Company provides rapid tests, laboratory tests and platform tests that improve decision making and are non-invasive, cost effective, as well as easy to perform.
Employees
25
Date Price Change Volume
26-06-29 SEK 0.4430 +5.23% 40,262
26-06-26 SEK 0.4210 -1.64% 2,940
26-06-25 SEK 0.4280 -1.15% 17,217
26-06-24 SEK 0.4330 +1.64% 21,886
26-06-23 SEK 0.4260 +1.91% 25,466

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IDLDX Stock